Literature DB >> 11150657

Purification and preliminary characterization of the zonula occludens toxin receptor from human (CaCo2) and murine (IEC6) intestinal cell lines.

S Uzzau1, R Lu, W Wang, C Fiore, A Fasano.   

Abstract

In the present study, we report the preliminary characterization of the epithelial cell receptor for Vibrio cholerae zonula occludens toxin (Zot). Zot receptor was purified by ligand-affinity chromatography. Analysis of affinity-purified preparations by polyacrylamide gel electrophoresis revealed a protein of ca. 66 kDa. Partial N-terminal sequence obtained from purified murine and human Zot receptor revealed homology between the two proteins and with human alpha-1-chimaerin. Zot protein domain(s) involved in receptor binding were also analyzed by constructing several in frame deletion derivatives of a recombinant fusion Zot protein tagged with maltose binding protein. Our results suggest that Zot binding to its cellular membrane receptor requires a sequence that spans between amino acids 118 and 299.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11150657     DOI: 10.1111/j.1574-6968.2001.tb09437.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  16 in total

1.  Intestinal zonulin: open sesame!

Authors:  A Fasano
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

2.  Cumulative protective efficacy of rZot and rAce combination in challenge experiments with wild type Vibrio cholerae in mouse model.

Authors:  Shaghayegh Anvari; Shahin Najar-Peerayeh; Mehrdad Behmanesh; Bita Bakhshi
Journal:  Hum Vaccin Immunother       Date:  2018-06-19       Impact factor: 3.452

3.  Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.

Authors:  Tammara Watts; Irene Berti; Anna Sapone; Tania Gerarduzzi; Tarcisio Not; Ronald Zielke; Alessio Fasano
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.

Authors:  Nusrat A Motlekar; Alessio Fasano; Mitchell S Wachtel; Bi-Botti C Youan
Journal:  J Drug Target       Date:  2006-06       Impact factor: 5.121

Review 5.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

6.  Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.

Authors:  Donna S Cox; Sangeeta Raje; Huanling Gao; Noha N Salama; Natalie D Eddington
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

Review 7.  Toxins and the gut: role in human disease.

Authors:  A Fasano
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

8.  Escherichia coli heat-stable toxin b impairs intestinal epithelial barrier function by altering tight junction proteins.

Authors:  Clément Ngendahayo Mukiza; J Daniel Dubreuil
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

Review 9.  Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms.

Authors:  Jeroen Visser; Jan Rozing; Anna Sapone; Karen Lammers; Alessio Fasano
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

10.  Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall.

Authors:  Alessio Fasano
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.